Pharmacokinetics, safety and tolerability of long‐acting parenteral intramuscular injection formulations of doravirine
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics, safety and tolerability of long‐acting parenteral intramuscular injection formulations of doravirine
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-06-05
DOI
10.1111/jcpt.13182
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Study to Evaluate Doravirine Pharmacokinetics When Coadministered With Acid-Reducing Agents
- (2019) Sauzanne G. Khalilieh et al. JOURNAL OF CLINICAL PHARMACOLOGY
- In Vitro Evaluation of the Drug Interaction Potential of Doravirine
- (2019) Kelly Bleasby et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Doravirine and Exposure-Response Analysis in Individuals with HIV-1
- (2019) Ka Lai Yee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Doravirine and the Potential for CYP3A-Mediated Drug–Drug Interactions
- (2019) Sauzanne G. Khalilieh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Investigation of Pharmacokinetic Interactions Between Doravirine and Elbasvir/Grazoprevir and Ledipasvir/Sofosbuvir
- (2019) Wendy Ankrom et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of the Pharmacokinetic Interaction Between Doravirine and Methadone
- (2019) Sauzanne Khalilieh et al. Clinical Pharmacology in Drug Development
- Evaluation of the Pharmacokinetics of Metformin Following Coadministration With Doravirine in Healthy Volunteers
- (2019) Rosa I. Sanchez et al. Clinical Pharmacology in Drug Development
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Characterisation of the absorption, distribution, metabolism, excretion and mass balance of doravirine, a non-nucleoside reverse transcriptase inhibitor in humans
- (2018) Rosa I. Sanchez et al. XENOBIOTICA
- Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial
- (2018) Jean-Michel Molina et al. Lancet HIV
- An Evaluation of Doravirine Pharmacokinetics When Switching From Efavirenz to Doravirine in Healthy Subjects
- (2016) Ka Lai Yee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Results of a doravirine-atorvastatin drug-drug interaction study
- (2016) Sauzanne Khalilieh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir
- (2016) Matt S. Anderson et al. CLINICAL PHARMACOKINETICS
- Current status and prospects of HIV treatment
- (2016) Tomas Cihlar et al. Current Opinion in Virology
- Modeling the Time Course of the Tissue Responses to Intramuscular Long-acting Paliperidone Palmitate Nano-/Microcrystals and Polystyrene Microspheres in the Rat
- (2015) Nicolas Darville et al. TOXICOLOGIC PATHOLOGY
- Intramuscular Administration of Paliperidone Palmitate Extended-Release Injectable Microsuspension Induces a Subclinical Inflammatory Reaction Modulating the Pharmacokinetics in Rats
- (2014) Nicolas Darville et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- In VitroCharacterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor
- (2013) Ming-Tain Lai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The end of AIDS: HIV infection as a chronic disease
- (2013) Steven G Deeks et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now